Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Deuruxolitinib effectively promotes hair regrowth in alopecia areata.

Baricitinib helps with severe hair loss, negative-pressure therapy lowers hernia recurrence, tranexamic acid reduces bleeding, robot-assisted breast surgery may improve outcomes, and acellular dermal matrix could decrease breast reconstruction complications.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Alopecia areata in Brazil causes significant psychosocial impacts, with limited access to advanced treatments, especially in public healthcare.

People with alopecia areata may have a higher risk of blood clots.

Alopecia areata is hard to treat, but new targeted therapies show promise.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Abrocitinib may effectively treat Lichen Planopilaris.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Modern treatments can effectively regrow hair and improve life for people with alopecia areata.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.